Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Cytochrome P2B6 on Efavirenz Dose in HIV-infected Thai Patients in a Prospective Randomized Controlled Trial: a Proof-of-concept Study

NCT02421289 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT02421289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02421289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Cytochrome P2B6 on Efavirenz Dose in HIV-infected Thai Patients in a Prospective Randomized Controlled Trial: a Proof-of-concept Study
Lead sponsor
Mahidol University
Phase
Phase 1
Overall status
Unknown status
Start date
April 30, 2013
Completion date
Not reported
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytochrome p-450 cyp2b6, efavirenz, hiv